Literature DB >> 26569479

Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.

Laura Eisenmenger1, Marie-Claire Porter2, Christopher J Carswell2, Andrew Thompson2, Simon Mead2, Peter Rudge2, John Collinge2, Sebastian Brandner2, Hans R Jäger3, Harpreet Hyare2.   

Abstract

IMPORTANCE: Prion diseases represent the archetype of brain diseases caused by protein misfolding, with the most common subtype being sporadic Creutzfeldt-Jakob disease (sCJD), a rapidly progressive dementia. Diffusion-weighted imaging (DWI) has emerged as the most sensitive magnetic resonance imaging (MRI) sequence for the diagnosis of sCJD, but few studies have assessed the evolution of MRI signal as the disease progresses.
OBJECTIVES: To assess the natural history of the MRI signal abnormalities on DWI in sCJD to improve our understanding of the pathogenesis and to investigate the potential of DWI as a biomarker of disease progression, with histopathological correlation. DESIGN, SETTING, AND PARTICIPANTS: Gray matter involvement on DWI was assessed among 37 patients with sCJD in 26 cortical and 5 subcortical subdivisions per hemisphere using a semiquantitative scoring system of 0 to 2 at baseline and follow-up. A total brain score was calculated as the summed scores in the individual regions. In 7 patients, serial mean diffusivity measurements were obtained. Age at baseline MRI, disease duration, atrophy, codon 129 methionine valine polymorphism, Medical Research Council Rating Scale score, and histopathological findings were documented. The study setting was the National Prion Clinic, London, England. All participants had a probable or definite diagnosis of sCJD and had at least 2 MRI studies performed during the course of their illness. The study dates were October 1, 2008 to April 1, 2012. The dates of our analysis were January 19 to April 20, 2012. MAIN OUTCOMES AND MEASURES: Correlation of regional and total brain scores with disease duration.
RESULTS: Among the 37 patients with sCJD in this study there was a significant increase in the number of regions demonstrating signal abnormality during the study period, with 59 of 62 regions showing increased signal intensity (SI) at follow-up, most substantially in the caudate and putamen (P < .001 for both). The increase in the mean (SD) total brain score from 30.2 (17.3) at baseline to 40.5 (20.6) at follow-up (P = .001) correlated with disease duration (r = 0.47, P = .003 at baseline and r = 0.35, P = .03 at follow-up), and the left frontal SI correlated with the degree of spongiosis (r = 0.64, P = .047). Decreased mean diffusivity in the left caudate at follow-up was seen (P < .001). Eight patients demonstrated decreased SI in cortical regions, including the left inferior temporal gyrus and the right lingual gyrus. CONCLUSIONS AND RELEVANCE: Magnetic resonance images in sCJD show increased extent and degree of SI on DWI that correlates with disease duration and the degree of spongiosis. Although cortical SI may fluctuate, increased basal ganglia SI is a consistent finding and is due to restricted diffusion. Diffusion-weighted imaging in the basal ganglia may provide a noninvasive biomarker in future therapeutic trials.

Entities:  

Mesh:

Year:  2016        PMID: 26569479      PMCID: PMC5837002          DOI: 10.1001/jamaneurol.2015.3159

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  30 in total

1.  MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan.

Authors:  R Fukushima; Y Shiga; M Nakamura; J Fujimori; T Kitamoto; Y Yoshida
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

2.  [Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease].

Authors:  S Kropp; M Finkenstaedt; I Zerr; A Schröter; S Poser
Journal:  Nervenarzt       Date:  2000-02       Impact factor: 1.214

3.  Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI.

Authors:  M Matoba; H Tonami; H Miyaji; H Yokota; I Yamamoto
Journal:  J Comput Assist Tomogr       Date:  2001 Mar-Apr       Impact factor: 1.826

4.  Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease.

Authors:  Sanjay Mittal; Peter Farmer; Peter Kalina; Peter B Kingsley; John Halperin
Journal:  Arch Neurol       Date:  2002-01

5.  Sequential MRI in a case of Creutzfeldt-Jakob disease.

Authors:  G G Tribl; G Strasser; J Zeitlhofer; S Asenbaum; C Jarius; P Wessely; D Prayer
Journal:  Neuroradiology       Date:  2002-03       Impact factor: 2.804

6.  Relationship between clinical course and Diffusion-weighted MRI findings in sporadic Creutzfeldt-Jakob Disease.

Authors:  Sang-Hun Yi; Key-Chung Park; Sung-Sang Yoon; Eui-Jong Kim; Won-Chul Shin
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

7.  Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study.

Authors:  Henriette J Tschampa; Petra Mürtz; Sebastian Flacke; Sebastian Paus; Hans H Schild; Horst Urbach
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

8.  Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; A Krasnianski; U Heinemann; D Varges; M Knauth; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

9.  Application of quantitative DTI metrics in sporadic CJD.

Authors:  E Caverzasi; R G Henry; P Vitali; I V Lobach; J Kornak; S Bastianello; S J Dearmond; B L Miller; H J Rosen; M L Mandelli; M D Geschwind
Journal:  Neuroimage Clin       Date:  2014-01-31       Impact factor: 4.881

10.  The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies.

Authors:  Andrew G B Thompson; Jessica Lowe; Zoe Fox; Ana Lukic; Marie-Claire Porter; Liz Ford; Michele Gorham; Gosala S Gopalakrishnan; Peter Rudge; A Sarah Walker; John Collinge; Simon Mead
Journal:  Brain       Date:  2013-04       Impact factor: 13.501

View more
  18 in total

Review 1.  Clinical Laboratory Tests Used To Aid in Diagnosis of Human Prion Disease.

Authors:  Allyson Connor; Han Wang; Brian S Appleby; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  [Sporadic Creutzfeldt-Jakob disease imitates posterior reversible encephalopathy syndrome].

Authors:  Schulamith Krüger; Jörg Larsen; Jens Schaumberg
Journal:  Nervenarzt       Date:  2019-06       Impact factor: 1.214

3.  Genetic and environmental influences on cortical mean diffusivity.

Authors:  Jeremy A Elman; Matthew S Panizzon; Donald J Hagler; Christine Fennema-Notestine; Lisa T Eyler; Nathan A Gillespie; Michael C Neale; Michael J Lyons; Carol E Franz; Linda K McEvoy; Anders M Dale; William S Kremen
Journal:  Neuroimage       Date:  2016-11-15       Impact factor: 6.556

Review 4.  Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.

Authors:  Peter Hermann; Brian Appleby; Jean-Philippe Brandel; Byron Caughey; Steven Collins; Michael D Geschwind; Alison Green; Stephane Haïk; Gabor G Kovacs; Anna Ladogana; Franc Llorens; Simon Mead; Noriyuki Nishida; Suvankar Pal; Piero Parchi; Maurizio Pocchiari; Katsuya Satoh; Gianluigi Zanusso; Inga Zerr
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

5.  Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.

Authors:  Kyan Younes; Julio C Rojas; Amy Wolf; Goh M Sheng-Yang; Matteo Paoletti; Gianina Toller; Eduardo Caverzasi; Maria Luisa Mandelli; Ignacio Illán-Gala; Joel H Kramer; Yann Cobigo; Bruce L Miller; Howard J Rosen; Michael D Geschwind
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

Review 6.  Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.

Authors:  Neetu Soni; Manish Ora; Girish Bathla; Chandana Nagaraj; Laura L Boles Ponto; Michael M Graham; Jitender Saini; Yusuf Menda
Journal:  Neuroradiol J       Date:  2021-03-05

7.  Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.

Authors:  Enrico De Vita; Gerard R Ridgway; Mark J White; Marie-Claire Porter; Diana Caine; Peter Rudge; John Collinge; Tarek A Yousry; Hans Rolf Jager; Simon Mead; John S Thornton; Harpreet Hyare
Journal:  Neuroimage Clin       Date:  2016-11-02       Impact factor: 4.881

8.  Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt-Jakob disease.

Authors:  Riccardo Pascuzzo; Neil P Oxtoby; Alexandra L Young; Janis Blevins; Gianmarco Castelli; Sara Garbarino; Mark L Cohen; Lawrence B Schonberger; Pierluigi Gambetti; Brian S Appleby; Daniel C Alexander; Alberto Bizzi
Journal:  Acta Neuropathol       Date:  2020-06-13       Impact factor: 17.088

9.  Putaminal diffusion tensor imaging measures predict disease severity across human prion diseases.

Authors:  Harpreet Hyare; Enrico De Vita; Marie-Claire Porter; Ivor Simpson; Gerard Ridgway; Jessica Lowe; Andrew Thompson; Chris Carswell; Sebastien Ourselin; Marc Modat; Liane Dos Santos Canas; Diana Caine; Zoe Fox; Peter Rudge; John Collinge; Simon Mead; John S Thornton
Journal:  Brain Commun       Date:  2020-04-08

10.  Epilepsia Partialis Continua as the First Presenting Symptom in Probable Sporadic Creutzfeldt-Jacob Disease: A Case Report and Literature Review.

Authors:  Sheng-Hsiang Yang; Poh-Shiow Yeh; Tai-Yuan Chen
Journal:  Case Rep Neurol       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.